Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success in 2020 until after that year’s election, the Wall Street Journal reported, citing ...

These followed two deals late last week – on Thursday GSK made an $85 million licensing agreement with Surface Oncology for an early-stage antibody asset, which adds a natural killer cell ...

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

Walmsley said there is a lot of data expected in 2020. Walmsley said in the interview that the next year could see “at least six approvals of new medicines or new indications”. GSK is asking ...

The GlaxoSmithKline Capital PLC-Bond was issued on the 5/12/2020 with a volume of 750 M. GBP. Indices Commodities Currencies Stocks ...

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

("GSK" or the "Company") (NYSE: GSK) American Depositary Receipts ("ADRs") between February 5, 2020, and August 14 ... the Deutsche Bank report stated that the total liability could be between $5 ...

Federal prosecutors in Manhattan are probing a claim by GSK ... in 2020 until after that year’s election, the Wall Street Journal reported, citing people familiar with the matter. The report ...